Arya Biomed, a leading provider of innovative respiratory care solutions, has made a significant impact in the market with its latest portable oxygen concentrator, the Arya Airtivo Max.
BOCA RATON, FL, January 06, 2023 /24-7PressRelease/ — Arya Biomed has established itself as a key player in the portable oxygen concentrator market, offering the lightest device in its class. The global portable oxygen concentrator market is anticipated to experience significant growth in the forecast period from 2022 to 2032, with a projected CAGR of 10.1%. The market is expected to reach a valuation of $1.9 billion by the end of 2022 and surpass $5.0 billion by 2032. In 2021, pulse flow portable oxygen concentrators led the market with a 67.7% share. The portable oxygen concentrator market was valued at approximately 54.8% of the overall $3.5 billion global oxygen concentrator market in 2021.
Arya Biomed, a leading provider of innovative respiratory care solutions, has made a significant impact in the market with its latest portable oxygen concentrator, the Arya Airtivo Max. The device, which is the lightest in its class, has quickly become a go-to choice for patients looking for a reliable and lightweight oxygen therapy device.
Portable oxygen concentrators supply oxygen to patients with respiratory diseases, such as chronic obstructive pulmonary disease (COPD). These devices separate nitrogen and oxygen from the air and provide 95% pure oxygen to patients through a mask, while discarding the nitrogen. Portable oxygen concentrators are preferred by patients as they are easily portable, andhey are also used by mountaineers and travelers in areas with low oxygen levels. Factors contributing to the growth of the portable oxygen concentrator market include an improved lifestyle and an increase in smoking rates. The growing geriatric population is increasing demand for home care settings, particularly in developed countries, while the rising number of patients with COPD and respiratory diseases is driving demand for portable oxygen concentrators. The adoption of portable oxygen concentrators is particularly significant in developing countries due to rising incomes and technological advancements, and the increasing number of COPD patients in countries like India and China will also contribute to global demand for these devices. Companies are investing in the production of continuous flow oxygen and focusing on improving the durability and production efficiency of oxygen concentrators to meet demand. An unhealthy lifestyle and the consumption of marijuana, cigars, and pipes by young people is also driving market growth, as is the shift from traditional concentrators to portable devices. The use of advanced technologies in the production of oxygen concentrators by manufacturers is also contributing to market growth.
In the competitive portable oxygen concentrator market, manufacturers are adopting various strategies to increase sales and revenue. In order to meet consumer demand and expand their businesses, companies are focusing on product innovation and introducing new products. They are also expanding their distribution channels and increasing their marketing efforts. Key players in the market include Invacare Corporation, Chart Industries, Inc., Koninklijke Philips N.V., AirSep Corporation, Inogen, Inc., and ResMed Inc., as well as Arya Biomed.
ARYA is changing the way people experience oxygen therapy from its lightweight design to its powerful operation. This pulse flow portable oxygen concentrator is a great fit for anyone that needs oxygen therapy but doesn’t want to be tied down. The powerful pulse flow operation is backed with a long-lasting battery so you can be out and about longer, and when you are free to charge your device, it’s as simple as charging your cell phone.
—
For the original version of this press release, please visit 24-7PressRelease.com here
